| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848919 | American Journal of Kidney Diseases | 2012 | 9 Pages |
Abstract
Paricalcitol is more effective than ergocalciferol at decreasing PTH levels in patients with CKD stages 3 or 4 with vitamin D deficiency and SHPT.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Csaba P. MD, Jun L. MD, Sandra M. PhD, MD, Dennis L. MD, Kamyar MD, PhD, Shahram MD,